|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 266, Issue 1 292-R305, Copyright © 1994 by American Physiological Society
ARTICLES |
P. F. Morrison, D. W. Laske, H. Bobo, E. H. Oldfield and R. L. Dedrick
Biomedical Engineering and Instrumentation Program, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892.
High-flow microinfusion provides a means for delivering macromolecules to large volumes of brain in easily obtainable time intervals. Slowly degraded approximately 180-kDa macromolecules, delivered at a constant volumetric flow rate of 3 microliters/min into homogeneous brain tissue (e.g., gray matter), would penetrate to a 1.5-cm radius in 12 h. The predicted concentration profile is relatively flat until it declines precipitously at the flow front. Hence, tissues are dosed rather uniformly, providing control over the undesired toxicity that may occur with alternative methods that depend on large concentration gradients for tissue transport. The penetration advantage of high-flow (convective) over low-flow (diffusive) microinfusion has been assessed at fixed pharmacodynamic effect. A 12-h high-flow microinfusion of a macromolecule degraded with a characteristic time of 33.5 h would provide 5- to 10-fold increases in volume over low-flow infusion and total treatment volumes > 10 cm3. Slower degradation rates would result in larger treatment volumes; more rapid degradation rates would reduce the volume but still favor convective over diffusive administration. This technique may be applicable to a variety of diagnostic and therapeutic agents such as radioimmunoconjugates, immunotoxins, enzymes, growth factors, and oligonucleotides.
This article has been cited by other articles:
![]() |
B. Perlstein, Z. Ram, D. Daniels, A. Ocherashvilli, Y. Roth, S. Margel, and Y. Mardor Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring Neuro-oncol, April 1, 2008; 10(2): 153 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sarntinoranont, M. J. Iadarola, R. R. Lonser, and P. F. Morrison Direct interstitial infusion of NK1-targeted neurotoxin into the spinal cord: a computational model Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R243 - R254. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, R. F. Barth, D. M. Adams, M. J. Ciesielski, R. A. Fenstermaker, S. Shukla, W. Tjarks, and M. A. Caligiuri Convection-enhanced Delivery of Boronated Epidermal Growth Factor for Molecular Targeting of EGF Receptor-positive Gliomas Cancer Res., November 15, 2002; 62(22): 6552 - 6558. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. McGuire and F. Yuan Quantitative analysis of intratumoral infusion of color molecules Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H715 - H721. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Y. Zhang, J. Luck, M. W. Dewhirst, and F. Yuan Interstitial hydraulic conductivity in a fibrosarcoma Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2726 - H2734. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Heimberger, G. E. Archer, R. E. McLendon, C. Hulette, A. H. Friedman, H. S. Friedman, D. D. Bigner, and J. H. Sampson Temozolomide Delivered by Intracerebral Microinfusion is Safe and Efficacious Against Malignant Gliomas in Rats Clin. Cancer Res., October 1, 2000; 6(10): 4148 - 4153. [Abstract] [Full Text] |
||||
![]() |
P. F. Morrison, M. Y. Chen, R. S. Chadwick, R. R. Lonser, and E. H. Oldfield Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R1218 - R1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. Kuan, C. J. Reist, C. F. Foulon, I. A. J. Lorimer, G. Archer, C. N. Pegram, I. Pastan, M. R. Zalutsky, and D. D. Bigner 125I-labeled Anti-Epidermal Growth Factor Receptor-vIII Single-Chain Fv Exhibits Specific and High-Level Targeting of Glioma Xenografts Clin. Cancer Res., June 1, 1999; 5(6): 1539 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Francis and B. O. Palsson Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion PNAS, November 11, 1997; 94(23): 12258 - 12262. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kalyanasundaram, V. D. Calhoun, and K. W. Leong A finite element model for predicting the distribution of drugs delivered intracranially to the brain Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1810 - R1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Chen and C. Nicholson Changes in brain cell shape create residual extracellular space volume and explain tortuosity behavior during osmotic challenge PNAS, July 18, 2000; 97(15): 8306 - 8311. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |